Articles From: Approximately 74% of S&P 500 Companies That have Reported Earnings Have Exceeded Projections to APS Adds to Solar Leadership in Arizona


2013/2/18
http://media.marketwire.com/attachments/201212/107982_FSE_Logo.gif http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=986827&ProfileId=051205&sourceType=1 NEW YORK, NY --
Sign-up for Approximately 74% of S&P 500 Companies That have Reported Earnings Have Exceeded Projections investment picks
2013/3/27
Web-based online video sees more users but far fewer minutes of use China smartphone panelists lead for average time spent with mobile online video COLUMBIA, Md.
Sign-up for Apps Dominate Video Online Consumption Across Seven Arbitron Mobile Smartphone Panels in the U.S., Europe, and Asia investment picks
2013/5/22
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1019844&ProfileId=051205&sourceType=1 STOCKHOLM, SWEDEN --
Sign-up for Apps for household solar-system monitoring and communication for disabled win top prizes in Ericsson Application Awards 2013 investment picks
2013/5/13
http://media.marketwire.com/attachments/201305/154229_apptech_logo_OTC.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1016751&ProfileId=051205&sourceType=1 WOODLANDS, TX --
Sign-up for AppTech Corp. Agrees to Merger With Transcendent One, Inc. investment picks
2013/5/6
Celgene International Sàrl, a subsidiary of Celgene Corporation (NASDAQ: CELG) today announced that statistical significance was achieved for the primary endpoint of ACR 20 at week 16 for patients receiving apremilast 20 mg and 30 mg BID monotherapy in PALACE 4.
Sign-up for Apremilast Achieves Statistical Significance for the Primary and Major Secondary Endpoints in Fourth Pivotal Phase III Study (PALACE 4) of Patients with Psoriatic Arthritis investment picks
2013/3/14
SAN DIEGO, March 14, 2013 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. ("Apricus Bio" or the "Company") (Nasdaq:APRI) ( www.apricusbio.com ) announced today that it will hold a conference call to discuss its year end 2012 financial results and recent corporate highlights on Monday, March 18, 2013 at 1:00 p.m. ET.
Sign-up for Apricus Biosciences Announces 2012 Year End Financial Results Conference Call investment picks
2013/3/14
SAN DIEGO, March 14, 2013 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. ("Apricus Bio" or the "Company") (Nasdaq:APRI) ( www.apricusbio.com ) today announced that it intends to cease financing its French subsidiaries, Finesco SAS, its French holding company, Scomedica SAS, its French sales company and NexMed Pharma SAS its marketing company.
Sign-up for Apricus Biosciences Announces Ceasing of Financing of French Subsidiaries investment picks
2013/5/7
SAN DIEGO, Calif., May 7, 2013 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. ("Apricus Bio" or the "Company") (Nasdaq:APRI) ( www.apricusbio.com ) announced today that it will hold a conference call to discuss its first quarter 2013 financial results and recent corporate highlights on Friday, May 10, 2013 at 9:00 a.m. ET.
Sign-up for Apricus Biosciences Announces First Quarter 2013 Financial Results Conference Call investment picks
2013/5/7
SAN DIEGO, May 7, 2013 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. ("Apricus Bio" or the "Company") (Nasdaq:APRI) ( www.apricusbio.com ) announced today that John P.
Sign-up for Apricus Biosciences Announces Poster Presentation of Vitaros(R) Data in Men Previously Unresponsive to PDE-5 Inhibitors at American Urological Association Annual Meeting investment picks
2013/5/22
SAN DIEGO, May 22, 2013 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. ("Apricus Bio" or the "Company") (Nasdaq:APRI) today announced that it intends to offer shares of common stock and warrants in an underwritten public offering.
Sign-up for Apricus Biosciences Announces Proposed Public Offering of Common Stock and Warrants investment picks
2013/4/1
SAN DIEGO, April 1, 2013 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. ("Apricus Bio" or the "Company") (Nasdaq:APRI) ( www.apricusbio.com ) today announced the sale of (1) Totect ® (dexrazoxane HCl), a marketed, injectable treatment for anthracycline extravasation, and (2) NitroMist ® (nitroglycerin sublingual aerosol), an FDA-approved nitrate vasodilator indicated for acute relief of an attack or acute prophylaxis of angina pectoris due to coronary artery disease.
Sign-up for Apricus Biosciences Announces Sale of Non-Core Assets investment picks
2013/3/18
SAN DIEGO, March 18, 2013 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. ("Apricus Bio" or the "Company") (Nasdaq:APRI) ( www.apricusbio.com ) today announced the appointment of Richard W.
Sign-up for Apricus Biosciences Appoints Richard W. Pascoe as Chief Executive Officer investment picks
2013/5/23
SAN DIEGO, May 23, 2013 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. ("Apricus Bio" or the "Company") (Nasdaq:APRI) today announced that it has priced an underwritten public offering of an aggregate of 6,000,000 shares of common stock at a price to the public of $2.85 per share, and warrants to purchase up to an aggregate of 3,000,000 shares of common stock for gross offering proceeds of $17,100,000. The shares of common stock and warrants are immediately separable and will be issued separately.
Sign-up for Apricus Biosciences Prices $17.1 Million Public Offering of Common Stock and Warrants investment picks
2013/3/18
SAN DIEGO, March 18, 2013 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. ("Apricus Bio" or the "Company") (Nasdaq:APRI) ( http://www.apricusbio.com ), today provided an update regarding ongoing corporate activities and announced that its Annual Report on Form 10-K for the quarter and year ended December 31, 2012 has been filed with the Securities and Exchange Commission earlier today.
Sign-up for Apricus Biosciences Provides Corporate Update; Files Annual Report for Quarter and Year Ended December 31, 2012 investment picks
2013/5/10
SAN DIEGO, May 10, 2013 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. ("Apricus Bio" or the "Company") (Nasdaq:APRI) ( http://www.apricusbio.com ), today provided an update regarding ongoing corporate activities and announced that it expects to file its Quarterly Report on Form 10-Q for the quarter ended March 31, 2013 with the Securities and Exchange Commission on Friday, May 10, 2013.
Sign-up for Apricus Biosciences Provides First Quarter 2013 Corporate Update investment picks
2013/6/10
SAN DIEGO, June 10, 2013 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. ("Apricus Bio" or the "Company") (Nasdaq:APRI) ( http://www.apricusbio.com ), today announced that its marketing application for Vitaros ® , indicated for the treatment of patients with erectile dysfunction ("ED"), has been approved through the European Decentralized Procedure ("DCP"). "The approval of Vitaros ® in Europe marks a significant milestone for Apricus Bio as we continue to execute on our core strategy of developing, seeking regulatory approval, and partnering our sexual health products," said Richard Pascoe, Chief Executive Officer of Apricus Bio.
Sign-up for Apricus Biosciences Receives European Approval for Vitaros(R) for the Treatment of Erectile Dysfunction investment picks
2013/4/18
SAN DIEGO, April 18, 2013 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. ("Apricus Bio" or the "Company") (Nasdaq:APRI) ( www.apricusbio.com ) announced today that Edward Cox, Vice President Corporate Development & Investor Relations, will present at the 2013 BIO International Convention on Wednesday, April 24, 2013 at 4:15 p.m. local time at McCormick Place, Chicago Bears Room, in Chicago, Illinois.
Sign-up for Apricus Biosciences to Present at 2013 BIO International Convention investment picks
2013/3/7
SAN DIEGO, March 7, 2013 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. ("Apricus Bio" or the "Company") (Nasdaq:APRI) ( www.apricusbio.com ) announced today that Edward Cox, Vice President Corporate Development & Investor Relations, will present at the BIO-Europe Spring 2013 Partnering Conference, being held in Barcelona, Spain.
Sign-up for Apricus Biosciences to Present at BIO-Europe Spring 2013 investment picks
2013/2/6
SAN DIEGO, Feb.
Sign-up for Apricus Biosciences to Present at the 15th Annual BIO CEO & Investor Conference investment picks
2013/3/13
SAN DIEGO, March 13, 2013 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. ("Apricus Bio" or the "Company") (Nasdaq:APRI) ( www.apricusbio.com ) announced today that Steve Martin, Interim Chief Executive Officer and Chief Financial Officer, will present at the 25th Annual ROTH Conference, being held at The Ritz Carlton in Dana Point, CA.
Sign-up for Apricus Biosciences to Present at the 25th Annual ROTH Conference investment picks
2013/5/22
Apricus Biosciences Inc. (APRI) unveiled plans to offer shares of common stock and warrants, while an affiliate of Lehman Brothers Holdings Inc. has commenced an offering of shares of AvalonBay Communities Inc. (AVB) and Equity Residential (EQR). Apricus, which focuses on developing drugs in the area of sexual health, didn't disclose how many shares and warrants.
Sign-up for Apricus, AvalonBay, Equity Residential Disclose Offerings investment picks
2013/4/1
April 1 Alert: Boston Pizza boots buns from its menu Canada NewsWire Guests get all doughy-eyed over restaurant chain's new "pizza-fied" dishes MISSISSAUGA, ON, April 1, 2013 /CNW/ - Boston Pizza, Canada's largest casual dining chain, today announced it is banning all buns from its menu and replacing them with pizza dough options.
Sign-up for April 1 Alert: Boston Pizza boots buns from its menu investment picks
2013/4/1
April 1 alert: WestJet eases restrictions on pets in the cabin Canada NewsWire Airline looks to attract more guests who want to travel with the family pet CALGARY , April 1, 2013 /CNW/ - WestJet today announced the easing of restrictions on pets in the cabin.
Sign-up for April 1 alert: WestJet eases restrictions on pets in the cabin investment picks
2013/5/15
U.S. shipments of major home appliances from manufacturers grew 9.2% in April from a year earlier, as appliance demand continued to draw momentum from an improving housing sector and better consumer confidence.
Sign-up for April Appliance Shipments Rise 9.2% From Year Ago investment picks
2013/4/5
April Events at Indigo Books & Music Canada NewsWire TORONTO , April 5, 2013 /CNW/ - From bestselling authors to the hottest spring releases, Indigo and Chapters stores nationally host FREE, and exclusive events through the month of April including appearances from Canadian music legend, Paul Anka , UFC  superstar, George St-Pierre, renowned tattoo artist Kat Von D and Toronto Blue Jays pitcher R.A. Dickey .
Sign-up for April Events at Indigo Books & Music investment picks
2013/4/2
LOS ANGELES , April 2, 2013 /PRNewswire/ -- April is National Safe Digging Month and Southern California Gas Co.
Sign-up for April Is National Safe Digging Month, SoCalGas Says 'Know What's Below', Call 811 Before You Dig investment picks
2013/5/1
- Total Volume Sets Record for Fourth Consecutive Month - Monthly ADV Reaches New High for Third Time in 2013 - New Single-Day Record Achieved on April 15 CHICAGO , May 1, 2013 /PRNewswire/ -- The CBOE Futures Exchange, LLC (CFE ® ) announced today that April 2013 was a record-setting month for the trading of futures on the CBOE Volatility Index ® (VIX ® ) with new all-time highs in total monthly volume, monthly average daily volume (ADV) and single-day  trading activity.
Sign-up for April Is Record-Setting Month For VIX Futures Trading At CFE investment picks
2013/4/2
- Avoid injury, property damage caused by digging into underground utilities - Miss Utility provides no-cost service to mark underground lines - Allow time for lines to be marked before starting to dig RICHMOND, Va.
Sign-up for April Is Safe Digging Month; Dominion Virginia Power Reminds You To Call 811 Before Digging investment picks
2013/5/23
WASHINGTON (MarketWatch) — Sales of new U.S. homes edged up in April to the second-highest post-recession level, as pent-up demand, low interest rates and tight inventories of older homes lifted demand.
Sign-up for April new-home sales second-best since recession investment picks
2013/4/3
An APS filing at the Arizona Corporation Commission underscores the company’s essential role in making Arizona one of the top solar energy markets in the nation.
Sign-up for APS Adds to Solar Leadership in Arizona investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Morningstar Investing Classroom Rewards (earn as you learn and redeem for Morningstar merchandise)
P   Morningstar Fund Analyst Reports (full research on 2,000 funds and ETFs)
P   Morningstar Stock Analyst Reports (full research on 2,000 stocks)
P   Morningstar Stock and Fund Stewardship Grades
P   Portfolio Manager (advanced with 10 x-ray analyses, including guidance)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: Approximately 74% of S&P 500 Companies That have Reported Earnings Have Exceeded Projections to APS Adds to Solar Leadership in Arizona
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity